BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6143912)

  • 1. Disease flare induced by D-Trp6-LHRH analogue in patients with metastatic prostatic cancer.
    Kahan A; Delrieu F; Amor B; Chiche R; Steg A
    Lancet; 1984 Apr; 1(8383):971-2. PubMed ID: 6143912
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse neurological symptoms after gonadotropin-releasing hormone analog therapy for in vitro fertilization cycles.
    Ashkenazi J; Goldman JA; Dicker D; Feldberg D; Goldman GA
    Fertil Steril; 1990 Apr; 53(4):738-40. PubMed ID: 2138573
    [No Abstract]   [Full Text] [Related]  

  • 3. Disease flare induced by luteinising hormone releasing hormone analogues in cancer patients.
    Deghenghi R; Misset JL
    Lancet; 1984 Jun; 1(8389):1302. PubMed ID: 6145013
    [No Abstract]   [Full Text] [Related]  

  • 4. Deslorelin. D-Trp-LHRH-PEA, LHRH agonist analogue, Somagard.
    Drugs R D; 1999 Dec; 2(6):420-2. PubMed ID: 10763456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dramatic aggravation of prostatic cancer at the onset of treatment with an LHRH agonist].
    Boumier P; Koeger AC; Camus JP
    Presse Med; 1985 May; 14(21):1200-1. PubMed ID: 3158996
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrocystic disease of the breast in premenopausal women: histohormonal correlation and response to luteinizing hormone releasing hormone analog treatment.
    Monsonego J; Destable MD; De Saint Florent G; Amouroux J; Kouyoundjian JC; Haour F; Breau JL; Israel L; Comaru-Schally AM; Schally AV
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1181-9. PubMed ID: 1852100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.
    Redding TW; Schally AV; Tice TR; Meyers WE
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5845-8. PubMed ID: 6237365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orchiectomy versus long-acting D-Trp-6-LHRH in advanced prostatic cancer.
    Parmar H; Edwards L; Phillips RH; Allen L; Lightman SL
    Br J Urol; 1987 Mar; 59(3):248-54. PubMed ID: 2952213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and maintenance of castration by an LHRH analogue: D-Trp6 LHRH or decapeptyl.
    Fretin J; Demerle F; Jardin A
    Prog Clin Biol Res; 1987; 243A():245-7. PubMed ID: 2958855
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma.
    Parmar H; Phillips RH; Lightman SL; Edwards L; Allen L; Schally AV
    Lancet; 1985 Nov; 2(8466):1201-5. PubMed ID: 2866289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolytic effect of D-Trp6-luteinizing hormone-releasing hormone in the rhesus monkey (Macaca mulatta).
    Asch RH; Siler-Khodr TM; Smith CG; Schally AV
    J Clin Endocrinol Metab; 1981 Mar; 52(3):565-71. PubMed ID: 6450776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic carcinoma of the prostate with leuprolide, an LHRH analogue.
    Smith JA
    Prog Clin Biol Res; 1985; 185A():279-85. PubMed ID: 3929267
    [No Abstract]   [Full Text] [Related]  

  • 13. LHRH analogues in prostatic cancer.
    Lancet; 1986 Feb; 1(8478):445-6. PubMed ID: 2868364
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aggravation of obstructive renal insufficiency by prostatic cancer treated with a gonadorelin agonist].
    Kerbrat P; Toussaint C; Gedouin D; Lobel B
    Presse Med; 1986 Feb; 15(4):165. PubMed ID: 2938124
    [No Abstract]   [Full Text] [Related]  

  • 16. Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.
    Waxman J; Man A; Hendry WF; Whitfield HN; Besser GM; Tiptaft RC; Paris AM; Oliver RT
    Br Med J (Clin Res Ed); 1985 Nov; 291(6506):1387-8. PubMed ID: 2933122
    [No Abstract]   [Full Text] [Related]  

  • 17. [An analog of gonadoliberin in the treatment of prostatic carcinoma].
    Mathé G; Schally AV; Vo Van ML; Duchier J; Misset JL; Keiling R
    Presse Med; 1984 Jun; 13(23):1443-5. PubMed ID: 6233591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical reversible castration with D-Trp-6-LH-RH microcapsules for the treatment of endometriosis. Preliminary results in a series of 51 patients.
    Zorn JR; Soubrane O; Siboni O; Papageorgiou G
    Contrib Gynecol Obstet; 1987; 16():254-9. PubMed ID: 2961507
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to studies on the treatment of cancer of the prostate with D-Trp6-LH-RH].
    Marcellino LR; Campanella A; Bandini M
    Biomed Pharmacother; 1987; 41(9-10):468-72. PubMed ID: 2968123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.